RegisterNET - A Registry for Neuroendocrine Tumors in the USA and Worldwide

计划入组 400 人 · 首次发布于 2014 年 10 月 21 日

Ga68-DOTA-NOC-PET Imaging of Neuroendocrine Tumors

计划入组 20 人 · 首次发布于 2007 年 12 月 7 日

Psychosocial Screening for Neuroendocrine Tumor Patients

计划入组 100 人 · 首次发布于 2017 年 12 月 13 日

Lutetium Lu 177 dotatate(Lutathera)

C₆₅H₈₇LuN₁₄O₁₉S₂

Copper oxodotreotide Cu-64

C₆₅H₈₈CuN₁₄O₁₉S₂

Tumor ncoantigen

Stiftung Swiss Tumor Institute

Switzerland

National Center for Tumor Diseases

Germany

Crinetics

United States

Neuroendocrine Tumor Pipeline Shows Promise with 75+ Therapies in Development and Recent FDA Approvals

ITM's Phase 3 Radiopharmaceutical Shows Promise in Neuroendocrine Tumor Treatment

Neuroendocrine Tumor Pipeline Shows Strong Growth with 75+ Therapies in Development